Antioxidant Activity of Calycosin against α-Synuclein Amyloid Fibrils-Induced Oxidative Stress in Neural-like Cells as a Model of Preventive Care Studies in Parkinson’s Disease
Abstract
Protein misfolding and aggregation result in induction of a number of neurodegenerative diseases. In the present study, the anti-fibrillation activity of calycosin and its influence on the amyloid formation of α-synuclein (α-syn) and associated cytotoxicity on neuron-like cells (PC-12) as a model of Parkinson's disease were explored. Therefore, in combination with ThT and ANS fluorescence assay, CD, Congo red absorbance, TEM and cytotoxicity assays (MTT, ROS, SOD activity, CAT activity, GSH content, and caspase-3 activity assays), we showed that calycosin remarkably inhibits α-syn fibril formation through a concentration-dependent manner. The experimental analysis indicated that calycosin exert its antioxidant effects against α-syn amyloid-triggered neurotoxicity by modifying the aggregation pathway toward formation of nontoxic spices via recovering the activity of SOD/CAT and GSH content and reducing the ROS content and caspase-3 activity. This work may provide useful information about the mechanism of α-syn amyloid inhibition by calycosin and pave the way for developing some small molecules-based therapeutic platforms against Parkinson's disease.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Increasing GSH levels in the brain is a possible therapy for PD.
“Increasing GSH levels in the brain is a possible therapy for PD, and multiple experimental investigations have shown this strategy works [44,45].”
From Neuroprotective Effects of Bifidobacterium breve CCFM1067 in MPTP-Induced Mouse Models of Parkinson’s Disease (2022) · cites this paper as [44]
The citation lists haven’t been fetched yet
References 36 · Cited by 32
- Authors
- Pan, Q., Ban, Y., & Khan, S.
- Affiliations
- First Hospital of China Medical University (CN)
- Second Affiliated Hospital of Zhengzhou University (CN)
- Corresponding author
- Pan, Qichen
- Khan, Suliman
- ORCID
- Khan, Suliman
- Venue
- International Journal of Biological Macromolecules
- Publisher
- Elsevier BV
- Published
- 2021-07
- Volume
- 182
- Pages
- 91-97
- ISSN
- 0141-8130 (ISSN-L)
- OpenAlex
- W3150574111
- Cited by
- 32
- References
- 36
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 7 · 2023: 6 · 2022: 7 · 2021: 2
- FWCI
- 2.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- International Journal of Biological Macromolecules (publishedVersion)
- PubMed (publishedVersion)
- Funders
- China Postdoctoral Science Foundation (2020M672291)
- Topics
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- calycosin, alpha-synuclein, amyloid fibril formation, Parkinson's disease, antioxidant activity, neuroprotection, PC12 cells, oxidative stress, protein aggregation, caspase-3, reactive oxygen species, superoxide dismutase, catalase, glutathione, neurotoxicity
- MeSH terms
- Amyloid, Animals, Antioxidants, Isoflavones, Neurons, Parkinson Disease, PC12 Cells, Oxidative Stress, Rats, alpha-Synuclein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review